Alkeon Capital Management’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-11,247
| Closed | -$1.08M | – | 132 |
|
|
2021
Q4 | $1.08M | Sell |
11,247
-13,753
| -55% | -$1.33M | ﹤0.01% | 134 |
|
|
2021
Q3 | $3.62M | Hold |
25,000
| – | – | 0.01% | 149 |
|
|
2021
Q2 | $4.62M | Hold |
25,000
| – | – | 0.01% | 140 |
|
|
2021
Q1 | $6.16M | Hold |
25,000
| – | – | 0.01% | 129 |
|
|
2020
Q4 | $7.05M | Buy |
25,000
+15,000
| +150% | +$4.23M | 0.01% | 122 |
|
|
2020
Q3 | $2.4M | Hold |
10,000
| – | – | ﹤0.01% | 120 |
|
|
2020
Q2 | $3.32M | Hold |
10,000
| – | – | 0.01% | 115 |
|
|
2020
Q1 | $2.28M | Hold |
10,000
| – | – | 0.01% | 106 |
|
|
2019
Q4 | $2.46M | Buy |
+10,000
| New | +$2.46M | 0.01% | 95 |
|